. Show Affiliations »
Abstract
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/pharmacokineticsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedDrugs, Investigational/adverse effectsDrugs, Investigational/pharmacokineticsDrugs, Investigational/therapeutic useHumansMultiple Sclerosis/drug therapyNeuroprotective Agents/adverse effectsNeuroprotective Agents/immunologyNeuroprotective Agents/pharmacokineticsNeuroprotective Agents/therapeutic useShock, Hemorrhagic/drug therapyStroke/drug therapy
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedDrugs, InvestigationalNeuroprotective Agentsrovelizumab
Year: 1999 PMID: 10565976 DOI: 10.2165/00126839-199901010-00009
Source DB: PubMed Journal: Drugs R D ISSN: 1174-5886